Nordea Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Nordea Investment Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.83M	Buy	107,157 +522	+0.5%	+$27.1K	0.01%	542
2026 Q1	$5.12M	Sell	106,635 -4,047	-4%	-$179K	﹤0.01%	578
2025 Q4	$4.54M	Sell	110,682 -20,392	-16%	-$818K	﹤0.01%	611
2025 Q3	$5.02M	Buy	131,074 +914	+0.7%	+$29.7K	﹤0.01%	593
2025 Q2	$3.58M	Buy	130,160 +2,110	+2%	+$53.7K	﹤0.01%	625
2025 Q1	$2.87M	Sell	128,050 -66,833	-34%	-$1.38M	﹤0.01%	636
2024 Q4	$3.82M	Buy	194,883 +8,257	+4%	+$188K	﹤0.01%	581
2024 Q3	$4.71M	Buy	+186,626	New	+$4.55M	0.01%	541
2024 Q2	–	Sell	-126,742	Closed	-$2.49M	–	929
2024 Q1	$2.49M	Buy	+126,742	New	+$2.48M	﹤0.01%	678

Other funds holding KNSA

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nordea Investment Management's KNSA Position: Q2 2026 in Review

Nordea Investment Management increased its Kiniksa Pharmaceuticals (KNSA) stake by 0.49% in Q2 2026, buying an estimated $27.1K and bringing the position to 107,157 shares worth $6.83M. The position accounts for 0.01% of the portfolio, ranked #542.

Nordea Investment Management first reported a position in KNSA in Q1 2024 and has held it in 9 quarters since. 69 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Nordea Investment Management held 107,157 shares of Kiniksa Pharmaceuticals worth $6.83M as of Q2 2026.
Nordea Investment Management bought 522 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $27.1K.
Kiniksa Pharmaceuticals made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #542 holding.
Nordea Investment Management first reported a position in Kiniksa Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
69 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.